Exact Sciences Corp (EXAS) Insider Trading

Last 12 months

Insiders sold $1.53M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Nov 2024.

Net open-market

−$1.53M

0 buys · 5 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

Nov 2024

Nov 13, 2024

Get an email when EXAS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 19, 2025	Jacob A Orville EVP, GM, Screening	Sold10b5-1 plan	5,000	$75.00	$375k	17%	Form 4
Nov 19, 2025	James Herriott SVP, General Counsel & Sec	Sold10b5-1 plan	1,000	$70.00	$70k	7.1%	Form 4
Nov 4, 2025	James Herriott SVP, General Counsel & Sec	Sold10b5-1 plan	1,500	$70.08	$105k	9.6%	Form 4
Nov 4, 2025	Brian Baranick EVP, GM, Precision Oncology	Sold10b5-1 plan	2,858	$70.08	$200k	11%	Form 4
Oct 24, 2025	Katherine S Zanotti Director	Sold10b5-1 plan	12,000	$65.00	$780k	16%	Form 4
Oct 9, 2025	James Herriott SVP, General Counsel & Sec	Sold10b5-1 plan	1,500	$60.00	$90k	8.8%	Form 4
Oct 9, 2025	James Edward Doyle Director	Sold10b5-1 plan	2,000	$60.00	$120k	3.3%	Form 4
Aug 13, 2025	James Edward Doyle Director	Sold10b5-1 plan	1,485	$42.02	$62k	2.4%	Form 4
Jun 13, 2025	Katherine S Zanotti Director	Sold10b5-1 plan	3,207	$53.20	$171k	4.2%	Form 4
Nov 13, 2024	Kevin T Conroy President and CEO	Bought	19,500	$51.35	$1M	1.7%	Form 4

Nov 19, 202510b5-1 plan
Jacob A Orville
EVP, GM, Screening · sold 5,000 at $75.00
$375k
17% of stake
Nov 19, 202510b5-1 plan
James Herriott
SVP, General Counsel & Sec · sold 1,000 at $70.00
$70k
7.1% of stake
Nov 4, 202510b5-1 plan
James Herriott
SVP, General Counsel & Sec · sold 1,500 at $70.08
$105k
9.6% of stake
Nov 4, 202510b5-1 plan
Brian Baranick
EVP, GM, Precision Oncology · sold 2,858 at $70.08
$200k
11% of stake
Oct 24, 202510b5-1 plan
Katherine S Zanotti
Director · sold 12,000 at $65.00
$780k
16% of stake
Oct 9, 202510b5-1 plan
James Herriott
SVP, General Counsel & Sec · sold 1,500 at $60.00
$90k
8.8% of stake
Oct 9, 202510b5-1 plan
James Edward Doyle
Director · sold 2,000 at $60.00
$120k
3.3% of stake
Aug 13, 202510b5-1 plan
James Edward Doyle
Director · sold 1,485 at $42.02
$62k
2.4% of stake
Jun 13, 202510b5-1 plan
Katherine S Zanotti
Director · sold 3,207 at $53.20
$171k
4.2% of stake
Nov 13, 2024
Kevin T Conroy
President and CEO · bought 19,500 at $51.35
$1M
1.7% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch EXAS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Medical Laboratories

NTRANATERA INC (Common Stock) – ticker 45E

FTREFortrea Holdings Inc.

RDNTRadNet Inc.

GHGuardant Health Inc.

CAICaris Life Sciences, Inc.

VCYTVeracyte Inc.

CDNACareDx Inc.

BLLNBillionToOne, Inc.

Spot a number that looks wrong? Check it in EXAS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EXAS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.